Moroccan businesswoman Lamia Tazi leads Sothema’s purchase of Soludia Maghreb
Lamia Tazi’s Sothema will buy 99.99% of the dialysis solutions provider to boost local production.
Skip to content
Lamia Tazi’s Sothema will buy 99.99% of the dialysis solutions provider to boost local production.
This boost comes on the heels of a strong rally in Sothema’s share price on the Casablanca Bourse.
Tazi, the chairperson of Sothema and one of the wealthiest investors on the Casablanca bourse owns an 8.4-percent stake in the leading healthcare group.
Each company not only reflects her strategic brilliance but also embodies her commitment to diversity, excellence, and positive global change.
Tazi is one of the most affluent investors on the Casablanca Stock Exchange.
Tazi holds a substantial 8.4-percent stake in Morocco’s leading healthcare company, Sothema, or 605,030 shares.
Tazi owns a significant 8.4-percent stake in Sothema.
Tazi owns a significant 8.4-percent stake in Sothema.
The French startup Ziwig is revolutionizing medical diagnostics.
Tazi is the chairperson and CEO of Sothema.
Sothema is Morocco’s leading healthcare firm.
Sothema produces more than 60 million units of pharmaceuticals every year.
Tazi owns a sizable 3.93-percent stake in the company, totaling 282,644 shares.
Sothema has grown into a leading pharmaceutical company in Africa and the Middle East.